Why Asia-Pacific attracts 60% of all ongoing and planned hepatology trials globally
There are more than 1,300 clinical trials in hepatology, either ongoing or planned, in Asia-Pacific. This represents about 60% of…
Read More…
Focus:
-
![]()
Clinical Trial Continuity in Asia-Pacific during the COVID-19 pandemic
The leading Asia-Pacific biotech specialist CRO Novotech is releasing a series of webinars about the advantages of conducting clinical trials…
Read More…
-
![]()
IRT: A competitive advantage to accelerate clinical trials during a global pandemic and beyond
Interactive Response Technology (IRT) can serve many different functions in clinical research, from patient randomisation to making data-driven calculations for…
Read More…
-
![covid-19 peru]()
Biotechs testing for COVID-19 in Asia-Pacific benefit from new fast-track review processes
Many countries in the Asia-Pacific region are now fast-tracking their COVID-19 clients’ clinical trials with expedited review processes for treatment…
Read More…
-
![]()
Data shows majority of Australian sites are open for clinical trial activity
Novotech, the Asia-Pacific CRO, has published data detailing the current status of clinical trials in the Asia-Pacific region during the…
Read More…
-
![mscs; covid-19]()
Managing the Covid-19 outbreak: Lessons learnt from South Korea
Due to its geographic proximity with China, South Korea was one of the first locations...
Read More...
-
![Asia-pacific clinical trials]()
Clinical trials data report for Asia-Pacific: Frost & Sullivan collaborates with Novotech
Business consulting firm Frost & Sullivan and Asia-Pacific CRO specialist Novotech published a report summarising the main trends and developments…
Read More…
-
![global CRO]()
Novotech case study: Global reach through CRO partnership for a phase 2 oncology trial
The alliance of regional specialists can provide the best of all worlds: global coverage, regional...
Read More...
-
![]()
Case studies in accelerating clinical trials in oncology
Clinical development in oncology and immunotherapies has accelerated dramatically over the past few years.
Read More...
-
![]()
Regulatory requirements for clinical trials: A comparison of Australia and the US
The regulatory environment in Australia and New Zealand offers a significant strategic opportunity for international...
Read More...
